Richard Ducray

779 total citations
17 papers, 554 citations indexed

About

Richard Ducray is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Richard Ducray has authored 17 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Richard Ducray's work include Quinazolinone synthesis and applications (4 papers), Synthesis and Catalytic Reactions (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Richard Ducray is often cited by papers focused on Quinazolinone synthesis and applications (4 papers), Synthesis and Catalytic Reactions (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Richard Ducray collaborates with scholars based in France, United Kingdom and United States. Richard Ducray's co-authors include Marco A. Ciufolini, Akiyuki Hamasaki, Dale L. Boger, Bernard Barlaam, Jason G. Kettle, Donald Ogilvie, Peter Ballard, Iain Simpson, Frédéric Jung and Francis J. Waller and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Richard Ducray

17 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Ducray France 13 371 208 93 43 37 17 554
Arvind Mathur United States 18 657 1.8× 243 1.2× 75 0.8× 35 0.8× 19 0.5× 87 983
Robert H. Bradbury United Kingdom 15 343 0.9× 279 1.3× 153 1.6× 69 1.6× 16 0.4× 34 623
Y. V. V. Srikanth India 15 590 1.6× 344 1.7× 72 0.8× 25 0.6× 39 1.1× 24 880
Onur Atasoylu United States 13 280 0.8× 193 0.9× 56 0.6× 15 0.3× 15 0.4× 17 488
Timo Heinrich Germany 19 519 1.4× 340 1.6× 95 1.0× 67 1.6× 88 2.4× 38 856
Dooseop Kim United States 16 689 1.9× 201 1.0× 115 1.2× 20 0.5× 43 1.2× 21 1.1k
Sven Ruf Germany 15 220 0.6× 393 1.9× 108 1.2× 22 0.5× 11 0.3× 31 741
G.M. Robertson United Kingdom 13 306 0.8× 393 1.9× 328 3.5× 30 0.7× 89 2.4× 27 874
Noel A. Powell United States 17 459 1.2× 309 1.5× 45 0.5× 72 1.7× 22 0.6× 29 751
Candido Gude United States 12 487 1.3× 196 0.9× 49 0.5× 50 1.2× 10 0.3× 24 670

Countries citing papers authored by Richard Ducray

Since Specialization
Citations

This map shows the geographic impact of Richard Ducray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Ducray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Ducray more than expected).

Fields of papers citing papers by Richard Ducray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Ducray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Ducray. The network helps show where Richard Ducray may publish in the future.

Co-authorship network of co-authors of Richard Ducray

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Ducray. A scholar is included among the top collaborators of Richard Ducray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Ducray. Richard Ducray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Degorce, Sébastien L., Bernard Barlaam, Elaine Cadogan, et al.. (2016). Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase. Journal of Medicinal Chemistry. 59(13). 6281–6292. 55 indexed citations
2.
Degorce, Sébastien L., Scott Boyd, Jon Curwen, et al.. (2016). Discovery of a Potent, Selective, Orally Bioavailable, and Efficacious Novel 2-(Pyrazol-4-ylamino)-pyrimidine Inhibitor of the Insulin-like Growth Factor-1 Receptor (IGF-1R). Journal of Medicinal Chemistry. 59(10). 4859–4866. 23 indexed citations
3.
Degorce, Sébastien L., Andrew Bailey, Rowena Callis, et al.. (2015). Investigation of (E)-3-[4-(2-Oxo-3-aryl-chromen-4-yl)oxyphenyl]acrylic Acids as Oral Selective Estrogen Receptor Down-Regulators. Journal of Medicinal Chemistry. 58(8). 3522–3533. 37 indexed citations
4.
Ducray, Richard, Iain Simpson, Frédéric Jung, et al.. (2011). Discovery of novel imidazo[1,2-a]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 21(16). 4698–4701. 44 indexed citations
5.
Ducray, Richard, Clifford D. Jones, Frédéric Jung, et al.. (2011). Novel imidazo[1,2-a]pyridine based inhibitors of the IGF-1 receptor tyrosine kinase: Optimization of the aniline. Bioorganic & Medicinal Chemistry Letters. 21(16). 4702–4704. 36 indexed citations
6.
Barlaam, Bernard, Richard Ducray, Christine Lambert‐van der Brempt, et al.. (2011). Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series. Bioorganic & Medicinal Chemistry Letters. 21(8). 2207–2211. 26 indexed citations
7.
Bardelle, Catherine, Bernard Barlaam, Nigel Brooks, et al.. (2010). Inhibitors of the tyrosine kinase EphB4. Part 3: Identification of non-benzodioxole-based kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(21). 6242–6245. 30 indexed citations
8.
Ducray, Richard, et al.. (2010). A versatile route to 3-(pyrimidin-4-yl)-imidazo[1,2-a]pyridines and 3-(pyrimidin-4-yl)-pyrazolo[1,5-a]pyridines. Tetrahedron Letters. 51(36). 4755–4758. 12 indexed citations
9.
Barlaam, Bernard, David Acton, Peter Ballard, et al.. (2008). Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 18(6). 1799–1803. 10 indexed citations
10.
Ducray, Richard, et al.. (2007). Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(3). 959–962. 70 indexed citations
11.
Barlaam, Bernard, Peter Ballard, Robert H. Bradbury, et al.. (2007). A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 18(2). 674–678. 18 indexed citations
12.
Hamasaki, Akiyuki, Richard Ducray, & Dale L. Boger. (2005). Two Novel 1,2,4,5-Tetrazines that Participate in Inverse Electron Demand Diels−Alder Reactions with an Unexpected Regioselectivity. The Journal of Organic Chemistry. 71(1). 185–193. 76 indexed citations
13.
Ducray, Richard & Marco A. Ciufolini. (2002). Total Synthesis of (±)‐FR66979. Angewandte Chemie International Edition. 41(24). 4688–4691. 38 indexed citations
14.
Ducray, Richard & Marco A. Ciufolini. (2002). Total Synthesis of (±)‐FR66979. Angewandte Chemie. 114(24). 4882–4885. 9 indexed citations
15.
Ducray, Richard, Nicolai Cramer, & Marco A. Ciufolini. (2001). Homo-Brook route to benzazocenols and congeners via allylsilane-derived aziridines. Tetrahedron Letters. 42(52). 9175–9178. 11 indexed citations
16.
Barrett, Anthony G. M., et al.. (2000). ChemInform Abstract: Lanthanoid Triflate and Triflide Catalyzed Atom Economic Nitration of Fluoroarenes.. ChemInform. 31(17). 5 indexed citations
17.
Waller, Francis J., Anthony G. M. Barrett, D. Christopher Braddock, et al.. (1999). Tris(trifluoromethanesulfonyl)methide (“Triflide”) Anion:  Convenient Preparation, X-ray Crystal Structures, and Exceptional Catalytic Activity as a Counterion with Ytterbium(III) and Scandium(III). The Journal of Organic Chemistry. 64(8). 2910–2913. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arvind Mathur Breakdown of academic impact, for papers by Robert H. Bradbury Breakdown of academic impact, for papers by Y. V. V. Srikanth Breakdown of academic impact, for papers by Onur Atasoylu Breakdown of academic impact, for papers by Timo Heinrich Breakdown of academic impact, for papers by Dooseop Kim Breakdown of academic impact, for papers by Sven Ruf Breakdown of academic impact, for papers by G.M. Robertson Breakdown of academic impact, for papers by Noel A. Powell Breakdown of academic impact, for papers by Candido Gude
Rankless by CCL
2026